Scandion Oncology announces share purchase by incoming President & CEO
Scandion Oncology, a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options today announced that the incoming President & CEO has purchased shares in the company.Incoming President & CEO Francois Martelet has reported that he has bought 11.184 shares. Persons under an obligation to report are persons discharging managerial responsibilities, as well as persons closely associated with them. For further information please contact: Johnny Stilou, Acting CEO & CFO Phone: +45 2960 3532 E-mail: jos@